← Back
Data updated: Mar 10, 2026
REMPEX
Infectious Disease
REMPEX is a specialty pharmaceutical company focused on Infectious Disease. Key products include VABOMERE.
1972
Since
2
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
Recent Activity
VABOMERE 2026-02-20
Labeling
MINOCIN 2025-03-31
Labeling
MINOCIN 2025-03-31
Labeling
MINOCIN 2025-03-31
Labeling
VABOMERE 2024-12-03
Labeling
MINOCIN 2024-07-18
Labeling
MINOCIN 2024-07-18
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...